Dabur India Limited — FDA Class II (D-0640-2026)

Dabur India Limited is recalling 4,944 tubes of a drug due to CGMP deviations. This recall is classified as a safety issue. The recall affects products distributed from their facility in Saily Village.

• •Dabur India Limited is recalling 4,944 tubes of a drug.
• •The recall is due to CGMP deviations.
• •This is classified as a Class II recall.
• •Consumers should check their medicine cabinets for the recalled product.
• •Recalls like this can lead to increased regulatory scrutiny.

Consumers who purchased the recalled drug should stop using it immediately. The recall affects 4,944 tubes, which could pose health risks.